文献速递烧伤创面修复

尼可地尔通过增强皮肤血流减少烧伤创面进展

Nicorandil reduces burn wound progression by enhancing skin blood flow.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2018-04-12

研究在大鼠梳状烧伤模型中评估尼可地尔是否减少烧伤创面进展,共使用24只大鼠。热损伤后分别予尼可地尔10或30 mg/kg灌胃,每日两次,持续3天。10 mg/kg与30 mg/kg剂量组在伤后第1天和第3天均显著增加淤滞带组织存活及皮肤灌注;30 mg/kg组还显著降低缺氧诱导因子-1α、核因子-κB p65表达及炎症反应。

要点

  • 大鼠梳状烧伤模型中,尼可地尔10与30 mg/kg组伤后第1、3天淤滞带组织存活显著增加。
  • 两剂量组伤后第1、3天淤滞带皮肤灌注均显著增加。
  • 30 mg/kg组伤后第1天缺氧诱导因子-1α与核因子-κB p65表达及炎症反应显著降低。

核心结论

  • 研究表明尼可地尔30 mg/kg给药方案通过减轻缺血再灌注损伤增加淤滞带组织存活。
  • 该效应由增强皮肤血流和减少炎症反应介导。
  • 作者认为尼可地尔对烧伤患者具有潜在临床应用价值。

研究设计与样本

  • 研究采用大鼠梳状烧伤模型,共使用24只大鼠。
  • 热损伤后予尼可地尔10或30 mg/kg灌胃,每日两次,持续3天。
  • 伤后第1天和第3天取皮肤行组织病理学检查与蛋白分离。

主要发现

  • 尼可地尔10 mg/kg与30 mg/kg组伤后第1天和第3天淤滞带组织存活显著增加。
  • 尼可地尔10 mg/kg与30 mg/kg组伤后第1天和第3天淤滞带皮肤灌注显著增加。
  • 30 mg/kg组伤后第1天淤滞带缺氧诱导因子-1α表达显著降低。
  • 30 mg/kg组伤后第1天淤滞带炎症反应减轻,包括多形核中性粒细胞浸润减少和白细胞介素-1β释放减少。
  • 30 mg/kg组伤后第1天淤滞带核因子-κB p65表达显著降低。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We assessed whether nicorandil, an adenosine triphosphate-sensitive K + channel opener, reduces burn wound progression in a rat comb burn model. A total of 24 rats were used. Following thermal injury, one dose of nicorandil (10 or 30 mg/kg) was administered intragastrically twice daily for 3 days. At days 1 and 3 after injury, skin was harvested for histopathological examination and protein isolation. Rats treated with the 10-mg/kg and 30-mg/kg doses of nicorandil exhibited significantly increased tissue survival in the zone of stasis at days 1 and 3 after injury. The 10-mg/kg and 30-mg/kg nicorandil doses also significantly increased skin perfusion in the zone of stasis at days 1 and 3 after injury. At 30 mg/kg, nicorandil significantly reduced hypoxia-inducible factor-1α expression in the zone of stasis at day 1 after injury and reduced inflammatory responses in the zone of stasis. The latter effect included decreased polymorphonuclear neutrophil leukocyte infiltration and interleukin-1β release at day 1 after injury. At 30 mg/kg, nicorandil also significantly reduced expression of nuclear factor-κB p65, akey transcriptional factor in the regulation of inflammatory mediators, in the zone of stasis at day 1 after injury. Our study demonstrates that a 30 mg/kg dosing schedule of nicorandil increases tissue survival in the zone of stasis by attenuating ischemia-reperfusion injury. This effect is mediated by the enhancement of skin blood flow and reduction in the inflammatory response. Therefore, our findings suggest that nicorandil has potential clinical applications for patients with burns.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. Choi J, Kim R, Kim J, et al. Nicorandil reduces burn wound progression by enhancing skin blood flow. J Plast Reconstr Aesthet Surg. 2018. PMID: 29748072. doi:10.1016/j.bjps.2018.03.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。